SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 857.58 |
| Enterprise Value ($M) | 1,581.77 |
| Book Value ($M) | -410.99 |
| Book Value / Share | -1.99 |
| Price / Book | -2.09 |
| NCAV ($M) | -476.52 |
| NCAV / Share | -2.31 |
| Price / NCAV | -1.80 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.52 |
| Return on Assets (ROA) | -0.44 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.12 |
| Current Ratio | 3.31 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 495.97 |
| Assets | 516.96 |
| Liabilities | 972.49 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 331.41 |
| Operating Income | -100.33 |
| Net Income | -226.54 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -95.14 |
| Cash from Investing | -131.50 |
| Cash from Financing | 32.48 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Avoro Capital Advisors LLC | 6.40 | ||
| 13G/A | Baker Bros. Advisors Lp | 4.98 | -46.81 | |
| 13G/A | Vanguard Group Inc | 8.67 | 25.06 | |
| 13G/A | State Street Corp | 6.24 | 14.83 | |
| 13G/A | BlackRock Inc. | 9.10 | 25.22 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 379,719 | 1,564,497 | 24.27 | |
| 421,220 | 2,735,562 | 15.40 | |
| 790,330 | 1,214,236 | 65.09 | |
| 605,483 | 1,137,604 | 53.22 | |
| 156,152 | 976,660 | 15.99 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AVRO – AVROBIO, Inc. | AVXL – Anavex Life Sciences Corp. |
| BBIO – BridgeBio Pharma, Inc. | BDTX – Black Diamond Therapeutics, Inc. |
| BEAM – Beam Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io